Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm
Provided By PR Newswire
Last update: Jun 10, 2025
NEW YORK, June 10, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) breached their fiduciary duties to shareholders.
Read more at prnewswire.com
